Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States

Infectious Diseases and Therapy

Volumn 6, Issue 4, 2017, Pages 477-486

  Parikh, Rohan C ^a   McLaurin, Kimmie K ^b   Margulis, Andrea V ^a   Mauskopf, Josephine ^a   Ambrose, Christopher S ^b   Pavilack, Melissa ^b   Candrilli, Sean D ^a  

^a RTI HEALTH SOLUTIONS   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Hospitalization; Infant; Preterm; Respiratory syncytial virus; RSV

Indexed keywords

ARTICLE; CHRONOLOGY; FEMALE; GESTATIONAL AGE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; UNITED STATES;

EID: 85036652861     PISSN: 21938229     EISSN: 21936382     Source Type: Journal    
DOI: 10.1007/s40121-017-0167-9     Document Type: Article

References (27)

1. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clin Infect Dis. 2012;54:1427–36.
2. Nair H, Nokes DJ, Gessner BD, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375:1545–55.
3. Jain S, Williams DJ, Arnold SR, et al. Community-acquired pneumonia requiring hospitalization among US children. N Engl J Med. 2015;372:835–45.
4. Ambrose CS, Anderson EJ, Simões EAF, et al. Respiratory syncytial virus disease in preterm infants in the US born at 32–35 weeks gestation not receiving immunoprophylaxis. Pediatr Infect Dis J. 2014;33:576–82.
5. Blanken MO, Koffijberg H, Nibbelke EE, Rovers MM, Bont L, Dutch RSV Neonatal Network. Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study. PLoS ONE. 2013;8:e59161.
6. Carbonell X, Fullarton JR, Gooch KL, Figueras-Aloy J. The evolution of risk factors for respiratory syncytial virus-related hospitalization in infants born at 32–35 weeks’ gestational age: time-based analysis using data from the FLIP-2 study. J Perinat Med. 2012;40:685–91.
7. Figueras-Aloy J, Carbonell-Estrany X, Quero J, IRIS Study Group. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33–35 weeks in Spain. Pediatr Infect Dis J. 2004;23:815–20.
8. Figueras-Aloy J, Quero-Jiménez J, Fernández-Colomer B, et al. Usefulness of different risk factor associations in predicting admissions due to respiratory syncytial virus in premature newborns of 32 to 35 weeks gestation in Spain [in Spanish]. Ann Pediatr (Barc). 2009;71:47–53.
9. Law BL, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J. 2004;23:806–14.
10. Resch B, Bramreiter VS, Kurath-Koller S, Freidl T, Urlesberger B. Respiratory syncytial virus associated hospitalizations in preterm infants of 29 to 32 weeks gestational age using a risk score tool for palivizumab prophylaxis. Eur J Clin Microbiol Infect Dis. 2017;36(6):1057.
11. Sommer C, Resch B, Simões EA. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol J. 2011;5:144–54.
12. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003;143(5):118–26.
13. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med. 2009;360:588–98.
14. Mauskopf J, Margulis A, Samuel M, Lohr KN. Respiratory syncytial virus hospitalizations in healthy preterm infants: systematic review. Pediatr Infect Dis J. 2016;35:e229–38.
15. Hall CB, Weinberg GA, Blumkin AK, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. 2013;132:e341–8.
16. Helfrich AM, Nylund CM, Eberly MD, Eide MB, Stagliano DR. Healthy late-preterm infants born 33–36 + 6 weeks gestational age have higher risk for respiratory syncytial virus hospitalization. Early Hum Dev. 2015;91:541–6.
17. Anderson EJ, Krilov LR, DeVincenzo JR, et al. SENTINEL1: an observational study of respiratory syncytial virus hospitalizations among US infants born at 29 to 35 weeks’ gestational age not receiving immunoprophylaxis. Am J Perinatol. 2017;34:51–61.
18. Agency for Healthcare Research and Quality. HCUP NIS Database Documentation. Healthcare Cost and Utilization Project (HCUP). 2016. https://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp. Accessed 25 Aug 2016.
19. Agency for Healthcare Research and Quality. KID Database Documentation. Healthcare Cost and Utilization Project (HCUP). 2016. https://www.hcup-us.ahrq.gov/db/nation/kid/kiddbdocumentation.jsp. Accessed 25 Aug 2016.
20. Chu HY, Steinhoff MC, Magaret A, et al. Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh. J Infect Dis. 2014;210:1582–9.
21. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr. 1981;98:708–15.
22. La Gamma EF, Kumar VR, Wadhawan R, et al. Receipt of palivizumab before birth hospitalization discharge among preterm infants in the United States. Am J Perinatol. 2015;32:1017–23.
23. Winterstein A, Knox CA, Kubilis P, Hampp C. Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: a cohort study. JAMA Pediatr. 2013;167:1118–24.
24. Dougherty NN, Meissner HC. Respiratory syncytial virus immunoprophylaxis. PediatrDrugs. 2000;1:127–32.
25. Boyce TG, Mellen BG, Mitchel EF, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr. 2000;31:865–70.
26. Fryzek JP, Martone WJ, Groothuis JR. Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study. Adv Ther. 2011;28:195–201.
27. Simoes EA, Anderson EJ, Wu X, Ambrose CS. Effects of chronologic age and young child exposure on respiratory syncytial virus disease among US preterm infants born at 32 to 35 weeks gestation. PLoS ONE. 2016;11:e0166226.